Experiments have shown that the introduction of protein BPI into the body in 80% of cases saves lives.
Researchers from Harvard Medical School in Boston have developed a new method to combat the effects of high and even fatal levels of radiation exposure. They are hooked up to this fight a protein called BPI (bactericidal / permeability-increasing protein), involved in immune response against gut harmful bacteria.
Assuming the existence of the healing properties of this protein, the researchers first decided to check what happens in the body after exposure. They examined 48 patients who received high doses of radiation resulted in damage to the bone marrow and found that the level of BPI protein in the blood of those patients fell an average in 71 times, and in some of patients, this protein was generally not found.
In principle, similar results were predictable. The damaged bone marrow stops producing white blood cells in the right quantities for the body, which are in a normal situation just contribute to the production of protein BPI.
Subsequent experiments were conducted on mice already. They were irradiated with a lethal dose of radiation and divided into three groups according to post-irradiation treatment: oral antibiotic "fluoroquinolon", antibiotic plus injection of BPI and untreated group.
Most of the control group mice died within 30 days. Antibiotic, as expected, increased the survival rate - about 40% of this group of mice was alive after one month. In the group of mice treated with the protein BPI, survival rose sharply to 80%.